{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:33:02Z","timestamp":1766853182262,"version":"3.48.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10716-8","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T04:42:21Z","timestamp":1750048941000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vitamin D3 augments cytotoxic effect of Itraconazole on chronic myelogenous leukemia cell line: a synergic effect on AMPK\/AKT signaling pathway"],"prefix":"10.1007","volume":"52","author":[{"given":"Moein","family":"Tahvili","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahid","family":"Nejati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaghub","family":"Pazhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"key":"10716_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"10716_CR2","doi-asserted-by":"publisher","unstructured":"Rodrigues R, Duarte D, Vale N (2022) Drug Repurposing in Cancer Therapy: Influence of Patient\u2019s Genetic Background in Breast Cancer Treatment. Int J Mol Sci 23. https:\/\/doi.org\/10.3390\/ijms23084280","DOI":"10.3390\/ijms23084280"},{"key":"10716_CR3","doi-asserted-by":"publisher","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A (2025) Cancer statistics, 2025. CA: A Cancer journal for clinicians n\/a. https:\/\/doi.org\/10.3322\/caac.21871","DOI":"10.3322\/caac.21871"},{"key":"10716_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/ajh.23404","volume":"87","author":"EH Estey","year":"2012","unstructured":"Estey EH (2012) Acute myeloid leukemia: 2012 update on diagnosis, risk stratification, and management. Am J Hematol 87:89\u201399. https:\/\/doi.org\/10.1002\/ajh.23404","journal-title":"Am J Hematol"},{"key":"10716_CR5","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1038\/s41375-019-0562-1","volume":"33","author":"M Baccarani","year":"2019","unstructured":"Baccarani M, Rosti G, Soverini S (2019) Chronic myeloid leukemia: the concepts of resistance and persistence and the relationship with the BCR-ABL1 transcript type. Leukemia 33:2358\u20132364. https:\/\/doi.org\/10.1038\/s41375-019-0562-1","journal-title":"Leukemia"},{"key":"10716_CR6","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/ajh.26642","volume":"97","author":"E Jabbour","year":"2022","unstructured":"Jabbour E, Kantarjian H (2022) Chronic myeloid leukemia: 2022 update on diagnosis, therapy, and monitoring. Am J Hematol 97:1236\u20131256. https:\/\/doi.org\/10.1002\/ajh.26642","journal-title":"Am J Hematol"},{"key":"10716_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin 72:7\u201333. https:\/\/doi.org\/10.3322\/caac.21708","journal-title":"CA Cancer J Clin"},{"key":"10716_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41408-023-00823-9","volume":"13","author":"J Senapati","year":"2023","unstructured":"Senapati J, Sasaki K, Issa GC, Lipton JH, Radich JP, Jabbour E, Kantarjian HM (2023) Management of chronic myeloid leukemia in 2023\u2013 common ground and common sense. Blood Cancer J 13:58. https:\/\/doi.org\/10.1038\/s41408-023-00823-9","journal-title":"Blood Cancer J"},{"key":"10716_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/bcp.14964","volume":"88","author":"S Islam","year":"2022","unstructured":"Islam S, Wang S, Bowden N, Martin J, Head R (2022) Repurposing existing therapeutics, its importance in oncology drug development: kinases as a potential target. Br J Clin Pharmacol 88:64\u201374. https:\/\/doi.org\/10.1111\/bcp.14964","journal-title":"Br J Clin Pharmacol"},{"key":"10716_CR10","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/s00210-022-02263-x","volume":"395","author":"KS Turabi","year":"2022","unstructured":"Turabi KS, Deshmukh A, Paul S, Swami D, Siddiqui S, Kumar U, Naikar S, Devarajan S, Basu S, Paul MK, Aich J (2022) Drug repurposing\u2014an emerging strategy in cancer therapeutics. Naunyn Schmiedebergs Arch Pharmacol 395:1139\u20131158. https:\/\/doi.org\/10.1007\/s00210-022-02263-x","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10716_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11033-024-10162-y","volume":"52","author":"LB Subay","year":"2024","unstructured":"Subay LB, Gencer Ak\u00e7ok EB, Ak\u00e7ok \u0130 (2024) Rapamycin and niacin combination induces apoptosis and cell cycle arrest through autophagy activation on acute myeloid leukemia cells. Mol Biol Rep 52:75. https:\/\/doi.org\/10.1007\/s11033-024-10162-y","journal-title":"Mol Biol Rep"},{"key":"10716_CR12","doi-asserted-by":"publisher","first-page":"38022","DOI":"10.18632\/oncotarget.16723","volume":"8","author":"RB Mokhtari","year":"2017","unstructured":"Mokhtari RB, Homayouni TS, Baluch N, Morgatskaya E, Kumar S, Das B, Yeger H (2017) Combination therapy in combating cancer. Oncotarget 8:38022\u201338043. https:\/\/doi.org\/10.18632\/oncotarget.16723","journal-title":"Oncotarget"},{"key":"10716_CR13","first-page":"1737","volume":"45","author":"A Tukmechi","year":"2014","unstructured":"Tukmechi A, Rezaee J, Nejati V, Sheikhzadeh N (2014) Effect of acute and chronic toxicity of Paraquat on immune system and growth performance in rainbow trout, O Ncorhynchus mykiss. Aquac Res 45:1737\u20131743","journal-title":"Aquac Res"},{"key":"10716_CR14","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1007\/s11033-012-1925-0","volume":"40","author":"J Sha","year":"2013","unstructured":"Sha J, Pan J, Ping P, Xuan H, Li D, Bo J, Liu D, Huang Y (2013) Synergistic effect and mechanism of vitamin A and vitamin D on inducing apoptosis of prostate cancer cells. Mol Biol Rep 40:2763\u20132768","journal-title":"Mol Biol Rep"},{"key":"10716_CR15","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41586-022-04437-2","volume":"603","author":"P Jaaks","year":"2022","unstructured":"Jaaks P, Coker EA, Vis DJ, Edwards O, Carpenter EF, Leto SM, Dwane L, Sassi F, Lightfoot H, Barthorpe S, van der Meer D, Yang W, Beck A, Mironenko T, Hall C, Hall J, Mali I, Richardson L, Tolley C, Morris J, Thomas F, Lleshi E, Aben N, Benes CH, Bertotti A, Trusolino L, Wessels L, Garnett MJ (2022) Effective drug combinations in breast, colon and pancreatic cancer cells. Nature 603:166\u2013173. https:\/\/doi.org\/10.1038\/s41586-022-04437-2","journal-title":"Nature"},{"key":"10716_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-023-02819-5","author":"KS Wakle","year":"2023","unstructured":"Wakle KS, Mokale SN, Sakle NS (2023) Emerging perspectives: unraveling the anticancer potential of vitamin D3. Naunyn Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-023-02819-5","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10716_CR17","doi-asserted-by":"publisher","first-page":"766978","DOI":"10.3389\/fcell.2021.766978","volume":"9","author":"K Bajbouj","year":"2021","unstructured":"Bajbouj K, Sahnoon L, Shafarin J, Al-Ali A, Muhammad JS, Karim A, Guraya SY, Hamad M (2021) Vitamin D-Mediated Anti-cancer activity involves Iron homeostatic balance disruption and oxidative stress induction in breast Cancer. Front Cell Dev Biol 9:766978. https:\/\/doi.org\/10.3389\/fcell.2021.766978","journal-title":"Front Cell Dev Biol"},{"key":"10716_CR18","doi-asserted-by":"publisher","unstructured":"Li Q, Li Y, Jiang H, Xiao Z, Wu X, Zhang H, Zhao Y, Du F, Chen Y, Wu Z, Li J, Hu W, Cho CH, Shen J, Li M (2021) Vitamin D suppressed gastric cancer cell growth through downregulating CD44 expression in vitro and in vivo. Nutrition 91\u201392:111413. https:\/\/doi.org\/10.1016\/j.nut.2021.111413","DOI":"10.1016\/j.nut.2021.111413"},{"key":"10716_CR19","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S1875-5364(15)30043-1","volume":"13","author":"RA Ness","year":"2015","unstructured":"Ness RA, Miller DD, Wei L (2015) The role of vitamin D in cancer prevention. Chin J Nat Med 13:481\u2013497. https:\/\/doi.org\/10.1016\/S1875-5364(15)30043-1","journal-title":"Chin J Nat Med"},{"key":"10716_CR20","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/boneres.2017.23","volume":"5","author":"Y Zheng","year":"2017","unstructured":"Zheng Y, Trivedi T, Lin RC, Fong-Yee C, Nolte R, Manibo J, Chen Y, Hossain M, Horas K, Dunstan C (2017) Loss of the vitamin D receptor in human breast and prostate cancers strongly induces cell apoptosis through downregulation of Wnt\/\u03b2-catenin signaling. Bone Res 5:17023. https:\/\/doi.org\/10.1038\/boneres.2017.23","journal-title":"Bone Res"},{"key":"10716_CR21","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.3892\/ol.2018.9072","volume":"16","author":"K Lan","year":"2018","unstructured":"Lan K, Yan R, Zhu K, Li W, Xu Z, Dang C, Li K (2018) Itraconazole inhibits the proliferation of gastric cancer cells in vitro and improves patient survival. Oncol Lett 16:3651\u20133657. https:\/\/doi.org\/10.3892\/ol.2018.9072","journal-title":"Oncol Lett"},{"key":"10716_CR22","doi-asserted-by":"publisher","first-page":"4333","DOI":"10.1002\/jcb.27719","volume":"120","author":"F Jiang","year":"2019","unstructured":"Jiang F, Xing HS, Chen WY, Du J, Ruan Yl, Lin AY, Zhou CZ (2019) Itraconazole inhibits proliferation of pancreatic cancer cells through activation of Bak-1. J Cell Biochem 120:4333\u20134341. https:\/\/doi.org\/10.1002\/jcb.27719","journal-title":"J Cell Biochem"},{"key":"10716_CR23","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3892\/ol.2021.13029","volume":"22","author":"PW Shen","year":"2021","unstructured":"Shen PW, Chou YM, Li CL, Liao EC, Huang HS, Yin CH, Chen CL, Yu SJ (2021) Itraconazole improves survival outcomes in patients with colon cancer by inducing autophagic cell death and inhibiting transketolase expression. Oncol Lett 22:768. https:\/\/doi.org\/10.3892\/ol.2021.13029","journal-title":"Oncol Lett"},{"key":"10716_CR24","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1111\/cas.16082","volume":"115","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Li L, Chu F, Wu H, Xiao X, Ye J, Li K (2024) Itraconazole inhibits tumor growth via CEBPB-mediated Glycolysis in colorectal cancer. Cancer Sci 115:1154\u20131169. https:\/\/doi.org\/10.1111\/cas.16082","journal-title":"Cancer Sci"},{"key":"10716_CR25","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/978-1-61779-080-5_20","volume":"731","author":"J van Meerloo","year":"2011","unstructured":"van Meerloo J, Kaspers GJ, Cloos J (2011) Cell sensitivity assays: the MTT assay. Methods Mol Biol 731:237\u2013245. https:\/\/doi.org\/10.1007\/978-1-61779-080-5_20","journal-title":"Methods Mol Biol"},{"key":"10716_CR26","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/978-1-61779-080-5_34","volume":"731","author":"IV Bijnsdorp","year":"2011","unstructured":"Bijnsdorp IV, Giovannetti E, Peters GJ (2011) Analysis of drug interactions. Methods Mol Biol 731:421\u2013434. https:\/\/doi.org\/10.1007\/978-1-61779-080-5_34","journal-title":"Methods Mol Biol"},{"key":"10716_CR27","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.7314\/apjcp.2014.15.3.1357","volume":"3","author":"G Al\u00e7o","year":"2014","unstructured":"Al\u00e7o G, \u0130\u011fdem \u015e, Dincer M, \u00d6zmen V, Sa\u011flam S, Selamo\u011flu D, Erdo\u011fan Z, Ordu C, Pilanc\u0131 KN, Bozdo\u011fan A (2014) Vitamin D levels in patients with breast cancer: importance of dressing style. Asian Pac J Cancer Prev 3:1357\u20131362. https:\/\/doi.org\/10.7314\/apjcp.2014.15.3.1357","journal-title":"Asian Pac J Cancer Prev"},{"key":"10716_CR28","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1158\/1940-6207.CAPR-10-0285","volume":"4","author":"JY Tang","year":"2011","unstructured":"Tang JY, Xiao TZ, Oda Y, Chang KS, Shpall E, Wu A, So P-L, Hebert J, Bikle D, Epstein EH (2011) Vitamin D3 inhibits Hedgehog signaling and proliferation in murine basal cell carcinomas. Cancer Prev Res 4:744\u2013751. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-10-0285","journal-title":"Cancer Prev Res"},{"key":"10716_CR29","doi-asserted-by":"publisher","first-page":"9039","DOI":"10.1038\/s41598-018-27297-1","volume":"8","author":"N Est\u00e9banez","year":"2018","unstructured":"Est\u00e9banez N, G\u00f3mez-Acebo I, Palazuelos C, Llorca J, Dierssen-Sotos T (2018) Vitamin D exposure and risk of breast cancer: a meta-analysis. Sci Rep 8:9039. https:\/\/doi.org\/10.1038\/s41598-018-27297-1","journal-title":"Sci Rep"},{"key":"10716_CR30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s12276-018-0038-9","volume":"50","author":"S-M Jeon","year":"2018","unstructured":"Jeon S-M, Shin E-A (2018) Exploring vitamin D metabolism and function in cancer. Exp Mol Med 50:20. https:\/\/doi.org\/10.1038\/s12276-018-0038-9","journal-title":"Exp Mol Med"},{"key":"10716_CR31","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.critrevonc.2015.11.006","volume":"98","author":"M Wahid","year":"2016","unstructured":"Wahid M, Jawed A, Mandal RK, Dar SA, Khan S, Akhter N, Haque S (2016) Vismodegib, Itraconazole and sonidegib as Hedgehog pathway inhibitors and their relative competencies in the treatment of basal cell carcinomas. Crit Rev Oncol Hematol 98:235\u2013241. https:\/\/doi.org\/10.1016\/j.critrevonc.2015.11.006","journal-title":"Crit Rev Oncol Hematol"},{"key":"10716_CR32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13046-017-0526-0","volume":"36","author":"Q Hu","year":"2017","unstructured":"Hu Q, Hou Y-C, Huang J, Fang J-Y, Xiong H (2017) Itraconazole induces apoptosis and cell cycle arrest via inhibiting Hedgehog signaling in gastric cancer cells. J Exp Clin Cancer Res 36:50. https:\/\/doi.org\/10.1186\/s13046-017-0526-0","journal-title":"J Exp Clin Cancer Res"},{"key":"10716_CR33","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/jcb.26211","volume":"119","author":"J Rezaie","year":"2018","unstructured":"Rezaie J, Mehranjani MS, Rahbarghazi R, Shariatzadeh MA (2018) Angiogenic and restorative abilities of human mesenchymal stem cells were reduced following treatment with serum from diabetes mellitus type 2 Patients. J Cell Biochem 119:524\u2013535. https:\/\/doi.org\/10.1002\/jcb.26211","journal-title":"J Cell Biochem"},{"key":"10716_CR34","first-page":"149","volume":"36","author":"K Inoue","year":"2016","unstructured":"Inoue K, Tsubamoto H, Sakata K, Sakane R, Hao H, Hirota S, Sonoda T, Shibahara H (2016) Expression of Hedgehog signals and growth Inhibition by Itraconazole in endometrial cancer. Anticancer Res 36:149\u2013153","journal-title":"Anticancer Res"},{"key":"10716_CR35","doi-asserted-by":"publisher","first-page":"E5954","DOI":"10.1073\/pnas.1803297115","volume":"115","author":"L Xing","year":"2018","unstructured":"Xing L, Anbarchian T, Tsai JM, Plant GW, Nusse R (2018) Wnt\/\u03b2-catenin signaling regulates ependymal cell development and adult homeostasis. Proc Natl Acad Sci 115:E5954\u2013e5962. https:\/\/doi.org\/10.1073\/pnas.1803297115","journal-title":"Proc Natl Acad Sci"},{"key":"10716_CR36","doi-asserted-by":"publisher","first-page":"711","DOI":"10.2147\/OTT.S117933","volume":"10","author":"C-m Yang","year":"2017","unstructured":"Yang C-m, Ji S, Li Y, Fu L-y, Jiang T, Meng F-d (2017) \u03b2-Catenin promotes cell proliferation, migration, and invasion but induces apoptosis in renal cell carcinoma. Onco Targets Ther 10:711\u2013724. https:\/\/doi.org\/10.2147\/OTT.S117933","journal-title":"Onco Targets Ther"},{"key":"10716_CR37","doi-asserted-by":"publisher","first-page":"8983","DOI":"10.1038\/sj.onc.1207115","volume":"22","author":"TF Franke","year":"2003","unstructured":"Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C (2003) PI3K\/Akt and apoptosis: size matters. Oncogene 22:8983","journal-title":"Oncogene"},{"key":"10716_CR38","doi-asserted-by":"crossref","unstructured":"Xu N, Lao Y, Zhang Y, Gillespie DA (2012) Akt: a double-edged sword in cell proliferation and genome stability. Journal of oncology 2012","DOI":"10.1155\/2012\/951724"},{"key":"10716_CR39","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.3892\/ijo.2018.4597","volume":"53","author":"GM Nitulescu","year":"2018","unstructured":"Nitulescu GM, Van De Venter M, Nitulescu G, Ungurianu A, Juzenas P, Peng Q, Olaru OT, Gr\u0103dinaru D, Tsatsakis A, Tsoukalas D (2018) The Akt pathway in oncology therapy and beyond. Int J Oncol 53:2319\u20132331. https:\/\/doi.org\/10.3892\/ijo.2018.4597","journal-title":"Int J Oncol"},{"key":"10716_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/172460080802300101","volume":"23","author":"J Cicenas","year":"2008","unstructured":"Cicenas J (2008) The potential role of Akt phosphorylation in human cancers. Int J Biol Markers 23:1\u20139. https:\/\/doi.org\/10.1177\/172460080802300101","journal-title":"Int J Biol Markers"},{"key":"10716_CR41","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1146\/annurev-physiol-060721-095517","volume":"84","author":"HR Spaulding","year":"2022","unstructured":"Spaulding HR, Yan Z (2022) AMPK and the adaptation to Exercise. Annu Rev Physiol 84:209\u2013227. https:\/\/doi.org\/10.1146\/annurev-physiol-060721-095517","journal-title":"Annu Rev Physiol"},{"key":"10716_CR42","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41420-024-02011-5","volume":"10","author":"N Wang","year":"2024","unstructured":"Wang N, Wang B, Maswikiti EP, Yu Y, Song K, Ma C, Han X, Ma H, Deng X, Yu R, Chen H (2024) AMPK\u2013a key factor in crosstalk between tumor cell energy metabolism and immune microenvironment?. Cell Death Discov 10:237. https:\/\/doi.org\/10.1038\/s41420-024-02011-5","journal-title":"Cell Death Discov"},{"key":"10716_CR43","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/embor.2009.10","volume":"10","author":"H Geng","year":"2009","unstructured":"Geng H, Wittwer T, Dittrich-Breiholz O, Kracht M, Schmitz ML (2009) Phosphorylation of NF\u2010\u03baB p65 at Ser468 controls its COMMD1\u2010dependent ubiquitination and target gene\u2010specific proteasomal elimination. EMBO Rep 10:381\u2013386. https:\/\/doi.org\/10.1038\/embor.2009.10","journal-title":"EMBO Rep"},{"key":"10716_CR44","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s00018-023-05098-8","volume":"81","author":"N Ebrahimi","year":"2024","unstructured":"Ebrahimi N, Abdulwahid A-HRR, Mansouri A, Karimi N, Bostani RJ, Beiranvand S, Adelian S, Khorram R, Vafadar R, Hamblin MR, Aref AR (2024) Targeting the NF-\u03baB pathway as a potential regulator of immune checkpoints in cancer immunotherapy. Cell Mol Life Sci 81:106. https:\/\/doi.org\/10.1007\/s00018-023-05098-8","journal-title":"Cell Mol Life Sci"},{"key":"10716_CR45","first-page":"1059","volume":"63","author":"X Chen","year":"2003","unstructured":"Chen X, Kandasamy K, Srivastava RK (2003) Differential roles of rela (p65) and c-Rel subunits of nuclear factor \u03baB in tumor necrosis factor-related apoptosis-inducing ligand signaling. Cancer Res 63:1059\u20131066","journal-title":"Cancer Res"},{"key":"10716_CR46","doi-asserted-by":"publisher","first-page":"6566","DOI":"10.1038\/s41388-019-0864-9","volume":"38","author":"S Gowrikumar","year":"2019","unstructured":"Gowrikumar S, Ahmad R, Uppada SB, Washington MK, Shi C, Singh AB, Dhawan P (2019) Correction: Upregulated claudin-1 expression promotes colitis-associated cancer by promoting beta-catenin phosphorylation and activation in Notch\/p-AKT-dependent manner. Oncogene 38:6566. https:\/\/doi.org\/10.1038\/s41388-019-0864-9","journal-title":"Oncogene"},{"key":"10716_CR47","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3892\/or.2015.4519","volume":"35","author":"SY Park","year":"2016","unstructured":"Park SY, Lee YK, Kim HJ, Park OJ, Kim YM (2016) AMPK interacts with beta-catenin in the regulation of hepatocellular carcinoma cell proliferation and survival with selenium treatment. Oncol Rep 35:1566\u20131572. https:\/\/doi.org\/10.3892\/or.2015.4519","journal-title":"Oncol Rep"},{"key":"10716_CR48","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.mce.2016.11.010","volume":"440","author":"SJ Mancini","year":"2017","unstructured":"Mancini SJ, White AD, Bijland S, Rutherford C, Graham D, Richter EA, Viollet B, Touyz RM, Palmer TM, Salt IP (2017) Activation of AMP-activated protein kinase rapidly suppresses multiple pro-inflammatory pathways in adipocytes including IL-1 receptor-associated kinase-4 phosphorylation. Mol Cell Endocrinol 440:44\u201356. https:\/\/doi.org\/10.1016\/j.mce.2016.11.010","journal-title":"Mol Cell Endocrinol"},{"key":"10716_CR49","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1080\/09168451.2018.1549974","volume":"83","author":"Y Wei","year":"2019","unstructured":"Wei Y, Zhou J, Yu H, Jin X (2019) AKT phosphorylation sites of Ser473 and Thr308 regulate AKT degradation. Biosci Biotechnol Biochem 83:429\u2013435. https:\/\/doi.org\/10.1080\/09168451.2018.1549974","journal-title":"Biosci Biotechnol Biochem"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10716-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10716-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10716-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:31:38Z","timestamp":1766853098000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10716-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10716"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10716-8","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2025,6,16]]},"assertion":[{"value":"22 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required for this type of study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate\/publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"598"}}